Leonteq Securities AG Invests $672,000 in Cigna Group $CI

Leonteq Securities AG bought a new position in Cigna Group (NYSE:CI) in the 4th quarter, Holdings Channel reports. The firm bought 2,443 shares of the health services provider’s stock, valued at approximately $672,000.

Several other institutional investors have also recently made changes to their positions in CI. Brighton Jones LLC lifted its holdings in shares of Cigna Group by 9.3% in the 4th quarter. Brighton Jones LLC now owns 3,736 shares of the health services provider’s stock worth $1,032,000 after acquiring an additional 318 shares during the last quarter. Sivia Capital Partners LLC lifted its holdings in shares of Cigna Group by 10.4% in the 2nd quarter. Sivia Capital Partners LLC now owns 1,160 shares of the health services provider’s stock worth $384,000 after acquiring an additional 109 shares during the last quarter. NewEdge Advisors LLC lifted its holdings in shares of Cigna Group by 4.5% in the 2nd quarter. NewEdge Advisors LLC now owns 22,225 shares of the health services provider’s stock worth $7,347,000 after acquiring an additional 958 shares during the last quarter. Treasurer of the State of North Carolina lifted its holdings in shares of Cigna Group by 16.6% in the 2nd quarter. Treasurer of the State of North Carolina now owns 148,840 shares of the health services provider’s stock worth $49,204,000 after acquiring an additional 21,173 shares during the last quarter. Finally, Osterweis Capital Management Inc. bought a new stake in shares of Cigna Group in the 2nd quarter worth about $163,000. Institutional investors own 86.99% of the company’s stock.

Cigna Group Trading Up 1.4%

Shares of CI opened at $286.06 on Friday. Cigna Group has a 1-year low of $239.51 and a 1-year high of $338.89. The company has a 50-day moving average of $276.63 and a 200 day moving average of $276.10. The firm has a market capitalization of $75.67 billion, a price-to-earnings ratio of 12.13, a PEG ratio of 0.99 and a beta of 0.30. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.73 and a quick ratio of 0.73.

Cigna Group (NYSE:CI) last announced its quarterly earnings data on Thursday, April 30th. The health services provider reported $7.79 earnings per share for the quarter, beating analysts’ consensus estimates of $7.60 by $0.19. Cigna Group had a net margin of 2.26% and a return on equity of 19.75%. The company had revenue of $68.52 billion during the quarter, compared to analyst estimates of $66.29 billion. During the same quarter last year, the business posted $6.74 EPS. The firm’s revenue for the quarter was up 4.6% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.350- EPS. On average, research analysts expect that Cigna Group will post 30.39 EPS for the current year.

Cigna Group Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, June 18th. Shareholders of record on Thursday, June 4th will be given a dividend of $1.56 per share. The ex-dividend date of this dividend is Thursday, June 4th. This represents a $6.24 dividend on an annualized basis and a yield of 2.2%. Cigna Group’s dividend payout ratio (DPR) is 26.45%.

Analyst Upgrades and Downgrades

CI has been the subject of several analyst reports. Robert W. Baird set a $337.00 target price on shares of Cigna Group in a report on Friday, May 1st. Raymond James Financial set a $340.00 target price on shares of Cigna Group in a report on Friday, May 1st. Barclays raised their target price on shares of Cigna Group from $303.00 to $310.00 and gave the stock an “overweight” rating in a report on Friday, May 1st. Mizuho set a $330.00 price objective on shares of Cigna Group in a report on Friday, May 1st. Finally, Royal Bank Of Canada lifted their price objective on shares of Cigna Group from $333.00 to $337.00 and gave the company an “outperform” rating in a report on Friday, May 1st. One investment analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and five have given a Hold rating to the company’s stock. Based on data from MarketBeat, Cigna Group currently has a consensus rating of “Moderate Buy” and a consensus target price of $339.80.

Insider Buying and Selling at Cigna Group

In other Cigna Group news, insider Everett Neville sold 1,719 shares of the firm’s stock in a transaction dated Monday, March 2nd. The shares were sold at an average price of $288.91, for a total transaction of $496,636.29. Following the transaction, the insider owned 5,670 shares of the company’s stock, valued at approximately $1,638,119.70. This trade represents a 23.26% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Nicole S. Jones sold 2,307 shares of the firm’s stock in a transaction dated Monday, March 2nd. The shares were sold at an average price of $288.91, for a total transaction of $666,515.37. Following the transaction, the insider directly owned 32,647 shares in the company, valued at $9,432,044.77. This trade represents a 6.60% decrease in their position. The SEC filing for this sale provides additional information. In the last quarter, insiders have sold 205,904 shares of company stock valued at $60,277,068. Company insiders own 0.60% of the company’s stock.

About Cigna Group

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.